Letter: Effectiveness of split-dose certolizumab pegol for Crohn's disease

Aliment Pharmacol Ther. 2013 Dec;38(11-12):1412. doi: 10.1111/apt.12506.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Certolizumab Pegol
  • Crohn Disease / drug therapy*
  • Drug Administration Schedule
  • Female
  • Humans
  • Immunoglobulin Fab Fragments / administration & dosage*
  • Immunosuppressive Agents / administration & dosage*
  • Male
  • Polyethylene Glycols / administration & dosage*
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin Fab Fragments
  • Immunosuppressive Agents
  • Polyethylene Glycols
  • Certolizumab Pegol